Skip to main content
. 2024 Jan 17;47:72–79. doi: 10.1016/j.jdcr.2023.11.027

Fig 5.

Fig 5

Case 2. A, Initial presentation of paronychia of several toes and pyogenic granulomas on bilateral first toes at month 6 of therapy with amivantamab. B, C, Continued paronychia and resolution of pyogenic granulomas 1 month after discontinuation of amivantamab.